Showing results (11-20 of 153) with videos related to
Sort By:
Pageof 16
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 5, 2025
Pitfalls in the Histological Diagnosis of Morphologic Variants of Invasive Lobular Carcinoma of the BreastGiuseppe Floris, Lounes Djerroudi, Gitte Zels, et al.Oncology Reports|July 26, 2006
Stable expression of temperature-sensitive p53: a suitable model to study wild-type p53 function in pancreatic carcinoma cellsDieter Nuevemann, Matthias Christgen, Hendrik Ungefroren, et al.Methods in Molecular Biology (Clifton, N.J.)|June 8, 2012
Detection of putative cancer stem cells of the side population phenotype in human tumor cell culturesMatthias Christgen, Matthias Ballmaier, Ulrich Lehmann, et al.The Thoracic and Cardiovascular Surgeon Reports|November 6, 2020
Cardiac Phlegmon: Infectious Endocarditis Causing Ventricular Wall RuptureFelix Fleißner, Igor Tudorache, Matthias Christgen, et al.Cancer Science|December 19, 2013
IPH-926 lobular breast cancer cells are triple-negative but their microarray profile uncovers a luminal subtypeMatthias Christgen, Robert Geffers, Hans Kreipe, et al.BMC Biotechnology|November 29, 2008
Reliable microRNA profiling in routinely processed formalin-fixed paraffin-embedded breast cancer specimens using fluorescence labelled bead technologyBritta Hasemeier, Matthias Christgen, Hans Kreipe, et al.International Journal of Cancer|March 15, 2021
Transcription factor AP-2beta in development, differentiation and tumorigenesisMieke Raap, Lisa Gierendt, Hans H Kreipe, et al.Journal of Cell Science|January 19, 2011
Intravital microscopy: new insights into metastasis of tumorsEvelyne Beerling, Laila Ritsma, Nienke Vrisekoop, et al.Cancer Letters|August 23, 2005
Gemcitabine-mediated apoptosis is associated with increased CD95 surface expression but is not inhibited by DN-FADD in Colo357 pancreatic cancer cellsMatthias Christgen, Bodo Schniewind, Astrid Jueschke, et al.Journal of Cell Science|August 25, 2018
Re-inforcing the cell death army in the fight against breast cancerClara R L Oudenaarden, Robert A H van de Ven, Patrick W B DerksenPageof 16